These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


63 related items for PubMed ID: 1549923

  • 1. Parathyroid hormone and calcium behavior in advanced congestive heart failure.
    Stefenelli T, Pacher R, Woloszczuk W, Glogar D, Kaindl F.
    Z Kardiol; 1992 Feb; 81(2):121-5. PubMed ID: 1549923
    [Abstract] [Full Text] [Related]

  • 2. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
    Cuppari L, Carvalho AB, Lobão RR, Martini LA, Cendoroglo M, Ventura RT, Draibe SA.
    Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
    [Abstract] [Full Text] [Related]

  • 3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H, Baradaran A.
    J Ayub Med Coll Abbottabad; 2004 Jul; 16(2):3-8. PubMed ID: 15455608
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcium-regulating peptide hormones and blood electrolytic balance in chronic heart failure.
    Arakelyan KP, Sahakyan YA, Hayrapetyan LR, Khudaverdyan DN, Ingelman-Sundberg M, Mkrtchian S, Ter-Markosyan AS.
    Regul Pept; 2007 Aug 16; 142(3):95-100. PubMed ID: 17368822
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 16; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute effects of 2 hours of moderate-intensity cycling on serum parathyroid hormone and calcium.
    Barry DW, Kohrt WM.
    Calcif Tissue Int; 2007 Jun 16; 80(6):359-65. PubMed ID: 17549534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S, Holubarsch C.
    Clin Sci (Lond); 2000 Jul 16; 99(1):27-35. PubMed ID: 10887055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Jul 16; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cica clamp evaluation of parathyroid responsiveness in chronic hypoparathyroidism: a sequential citrate and calcium clamp study.
    Schwarz P, Hyldstrup L, Transbøl I.
    Miner Electrolyte Metab; 1994 Jul 16; 20(3):135-40. PubMed ID: 7816002
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the calcium-PTH axis and renal handling of phosphate by calcium and citrate clamp techniques in normal subjects and in patients with heavy proteinuria.
    Saha H, Seppälä E, Mörsky P, Mustonen J, Pasternack A.
    Clin Nephrol; 1997 Dec 16; 48(6):364-70. PubMed ID: 9438095
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.